Search Results 231-240 of 16582 for ������������KA���:ZA31���24������ ���������������������������������

  1. High-risk pregnancy: Know what to expect - Mayo Clinic

    24, 2023. Preconception health. Office on Women's Health. https://www.womenshealth.gov/pregnancy/you-get-pregnant/preconception-health. Accessed Oct. 24, 2023.

  2. Clinical trials - Psychiatry and Psychology

    ... 24-hr post-infusion change in depression (MADRS) in 30 TRD adults. A Study to Build Translational Science through an Online Social Media Community ...

  3. Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as vincristine liposomal ...

  4. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    OR > 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; OR serum immunoglobulin free light chain ≥ 10 mg/dL AND abnormal serum ...

  5. Outcomes Measures in Patients Undergoing Pancreatectomy - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-005339. Sponsor Protocol Number: 24-005339. About this study. The purpose of this study is to evaluate a longitudinal analysis ...

  6. Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis (BRAIVE IDE) - Mayo Clinic

    The primary objective of this study is to demonstrate that the mean change in pre-operative main thoracic Cobb angle, compared to post-oprative Cobb angle at 24 ...

  7. Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) - Mayo Clinic

    ... 24 hours after randomization 6. Weight is less than 40 kg or more than 125 ... 24 hours) 8. Sepsis diagnosis according to sepsis inclusion criteria for ...

  8. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Part B: To demonstrate the efficacy of dupilumab treatment compared with placebo in adult and adolescent patients with EoE after 24 weeks of treatment as ...

  9. A Study of Rilvegostomig Plus Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection - Mayo Clinic

    Jacksonville, Florida: 24-004014; Scottsdale/Phoenix, Arizona: 24-004014. NCT ID: NCT06109779. Sponsor Protocol Number: D7025C00001. About this study. The ...

  10. A Study of KK2269 in Adult Participants With Solid Tumors - Mayo Clinic

    Jacksonville, Florida: 24-013884; Scottsdale/Phoenix, Arizona: 24-013884. NCT ID: NCT06266299. Sponsor Protocol Number: 2269-001. About this study. This is a ...